Skip NavigationSkip to Content
Return Return to Search Results

A short review on antibody therapy for COVID-19

  1. Author:
    Kumar, G. Venkat
    Ramakrishnan, S.
    Ramakrishnan,Saminathan

  2. Author Address

    Ponnaiyah Ramajayam Inst Sci & Technol, Dept Biotechnol, Thanjavur 613403, Tamil Nadu, India.SRM Arts & Sci Coll, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India.NCI, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21702 USA.
    1. Year: 2020
    2. Date: MAY
    3. Epub Date: 2020 04 20
  2. Journal: New microbes and new infections
  3. ELSEVIER SCI LTD,
    1. 35
  5. Type of Article: Review
  6. Article Number: 100682
  7. ISSN: 2052-2975
  1. Abstract:

    The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-2. In addition to supportive treatment, such as oxygen supply in moderate cases and extracorporeal membrane oxygenation in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed the antibody therapy might be an immediate strategy for emergency prophylaxis and SARS-CoV-2 therapy. (C) 2020 The Authors. Published by Elsevier Ltd.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.nmni.2020.100682
  3. PMID: 32313660
  4. PMCID: PMC7167584
  5. View record in Web of Science®
  6. WOS: 000572908800016

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel